Can you take Vyvanse (lisdexamfetamine) with Celebrex (celecoxib) and Flexeril (cyclobenzaprine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concomitant Use of Vyvanse with Celebrex and Flexeril

Taking Vyvanse (lisdexamfetamine) with Celebrex (celecoxib) and Flexeril (cyclobenzaprine) should be avoided due to potential serious drug interactions, particularly the risk of serotonin syndrome with cyclobenzaprine and increased cardiovascular risks when combining stimulants with NSAIDs.

Potential Interactions and Risks

Vyvanse (Lisdexamfetamine)

  • Vyvanse is a prodrug that converts to dextroamphetamine, a central nervous system stimulant used for ADHD treatment 1
  • It works by inhibiting dopamine and norepinephrine transporters and promoting neurotransmitter release 1
  • Can increase blood pressure and heart rate, which may compound cardiovascular risks when combined with NSAIDs 2

Celebrex (Celecoxib)

  • Celecoxib is a COX-2 selective NSAID that carries cardiovascular risks including increased risk of myocardial infarction, stroke, and heart failure 2
  • The American Heart Association has issued warnings about cardiovascular events with COX-2 inhibitors 2
  • Celecoxib can cause renal toxicity through inhibition of prostaglandin synthesis 3

Flexeril (Cyclobenzaprine)

  • Cyclobenzaprine is a muscle relaxant that has been associated with serotonin syndrome when combined with other serotonergic medications 4
  • Has a chemical structure similar to tricyclic antidepressants and may affect serotonin levels 4

Specific Interaction Concerns

Cardiovascular Risks

  • Both Vyvanse (as a stimulant) and Celebrex can independently increase cardiovascular risks 2, 1
  • Combining these medications may potentially compound these risks, leading to:
    • Increased blood pressure 2, 3
    • Higher risk of cardiovascular events 2
    • Worsening of existing hypertension 3

Serotonin Syndrome Risk

  • Cyclobenzaprine (Flexeril) has been reported to precipitate serotonin syndrome when combined with serotonergic medications 4
  • Amphetamines like the active metabolite of Vyvanse can affect serotonin levels, potentially increasing this risk 1
  • Symptoms of serotonin syndrome include agitation, hallucinations, rapid heart rate, fever, excessive sweating, shivering, tremor, muscle stiffness, coordination problems, and gastrointestinal symptoms 4

Renal Concerns

  • Both Celebrex and Vyvanse can affect kidney function 3
  • Celebrex can cause volume-dependent renal failure and other renal complications 3
  • The combination may increase the risk of renal adverse effects 3

Recommendations

Alternative Approaches

  • Consider alternative pain management options instead of combining these medications 3, 5
  • For pain management:
    • Acetaminophen may be a safer alternative for pain relief than Celebrex when taking Vyvanse 5
    • Non-pharmacological approaches such as physical therapy for muscle spasms 5
    • If NSAID therapy is necessary, consider using the lowest effective dose for the shortest duration 2, 5

If These Medications Must Be Used

  • Close monitoring for:
    • Signs of serotonin syndrome (confusion, agitation, muscle rigidity, fever, sweating, tremor) 4
    • Cardiovascular effects (blood pressure, heart rate) 2, 3
    • Renal function 3
    • Gastrointestinal symptoms 3, 5

Special Considerations

  • Elderly patients are at particularly high risk for adverse effects from these medications 5
  • Patients with pre-existing cardiovascular disease should especially avoid this combination 2, 3, 5
  • Patients with renal impairment are at higher risk for complications 3

Conclusion

The combination of Vyvanse with both Celebrex and Flexeril carries significant risks, particularly cardiovascular concerns and potential serotonin syndrome. Alternative treatment approaches should be strongly considered, and if these medications must be used together, close monitoring is essential.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Risks Associated with Concomitant Use of Celecoxib and Meloxicam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report.

The American journal of emergency medicine, 2008

Guideline

Considerations for Using Celebrex (Celecoxib) in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.